Salix (SLXP) Falls 23 percent

Salix Pharmaceutics Ltd. (SLXP) tumbled 23% to $32.14 for the biggest retreat in the Russell 2000 Index. The drugmaker said the FDA wasn’t ready to approve at this time its Xifaxan drug for treating non-constipation irritable bowel syndrome without more information.

Create Content With AI

Risk Our Money Not Yours | Get 50% Off Any Account

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


*

This site uses Akismet to reduce spam. Learn how your comment data is processed.